Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.80 USD
+0.02 (0.05%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $41.84 +0.04 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.80 USD
+0.02 (0.05%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $41.84 +0.04 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
Zacks News
3 Top Stocks From the Booming US Medical Products Industry
by Sreyoshi Mukherjee
The U.S. Medical Products industry is sturdy on solid focus on technological advancement.
GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%
by Zacks Equity Research
GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Medical - Products Stock Outlook: Short-Term Pain Inevitable
by Zacks Equity Research
Near-term growth prospects of medical products are being questioned due to trade war apprehensions and President Trump's imposition of fresh tariffs on about $200 billion on Chinese imports.
Here's Why You Should Invest in Surmodics (SRDX) Stock Now
by Zacks Equity Research
Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.
Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod
by Zacks Equity Research
The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.
Why Is SurModics (SRDX) Up 19.9% Since Last Earnings Report?
by Zacks Equity Research
SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries
by Zacks Equity Research
Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries
4 of the Best Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International
by Zacks Equity Research
Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International
4 Winning Stocks With Solid Efficiency Level
by Tirthankar Chakraborty
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid
by Zacks Equity Research
Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.
Surmodics (SRDX) Beats Q3 Earnings Estimates, Raises '18 View
by Zacks Equity Research
Surmodics' (SRDX) third-quarter fiscal 2018 results benefit from increase in royalty and license fee revenues.
SurModics (SRDX) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
SurModics (SRDX) delivered earnings and revenue surprises of 437.50% and 12.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Top Performing Stocks of the Best ETF of 1H2018
by Sweta Killa
Inside the top performing stocks of the top ETF of the first half of 2018.
Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips
by Zacks Equity Research
Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips
4 of the Best Efficient Stocks to Buy for Superb Returns
by Tirthankar Chakraborty
We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns
Here's Why You Must Add Surmodics (SRDX) to Your Portfolio
by Zacks Equity Research
Surmodics' (SRDX) efforts to improve research and development stature bode well.
SYK or SRDX: Which is a Better Medical Product Stock?
by Zacks Equity Research
Stryker (SYK) and Surmodics' (SRDX) strong fundamentals and rising share price make them close contenders.
Baxter (BAX) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.
4 Medical Device Stocks with Solid Potential to Buy Now
by Zacks Equity Research
The Medical Device tax suspension spells good times for MedTech bigwigs.
Surmodics (SRDX) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.
Surmodics (SRDX) Gains From Consistent Efforts to Boost R&D
by Zacks Equity Research
Surmodics' (SRDX) consistent focus on research and development activities has been driving growth. The company is expected to make continued progress throughout the remainder of fiscal 2018.
Zacks.com featured highlights include: Marine Products, Illumina, Chemed, Surmodics and MAM
by Zacks Equity Research
Zacks.com featured highlights include: Marine Products, Illumina, Chemed, Surmodics and MAM
Baxter International (BAX) Hits a 52-Week High, Can the Run Continue?
by Zacks Equity Research
Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.
5 Top Efficient Stocks to Keep on Your Radar
by Tirthankar Chakraborty
We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns